- There were no results found.
Recent Content
- Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma
- Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma Australia
- Shah on the Potential Utility of NK Cells in Multiple Myeloma
- Dr. Popat on Investigational Strategies for Belantamab Mafodotin–Related Keratopathy in Multiple Myeloma
- Monoklonal gammopati av klinisk betydning
- Roadmap to cure multiple myeloma
- Oncopeptides withdraws multiple myeloma therapy from U.S. market
- The Myeloma Nurse Who Climbed a Mountain to Connect With Her Patients
- Oncopeptides Withdraws Melphalan Flufenamide Myeloma Indication in the United States
- Driving Treatment Decisions and Predicting Long-Term Outcomes in Multiple Myeloma